Vivifrail multicomponent exercise protocol

Vivifrail multicomponent exercise protocol has been studied in 1 paper since 2025: 1 trial in people. The newest paper, Mar 4, 2025: “Effects of the VIVIFRAIL Exercise Protocol on Circulatory and Intracellular Peripheral Mediators Bridging Mitochondrial Dynamics and Inflammation in Robust and Frail Older People”.

Intervention

1 paper studies it4 findingsUpdated

See all 1 papers on vivifrail multicomponent exercise protocol

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“Besides significant functional improvements across both groups”
Effects of the VIVIFRAIL Exercise Protocol on Circulatory and Intracellular Peripheral Mediators Bridging Mitochondrial Dynamics and Inflammation in Robust and Frail Older PeopleAging cell2025doi:10.1111/acel.70029

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funder: Fondazione Cariplo
  • Human trial1

Studies in people

1 study gave vivifrail multicomponent exercise protocol to people and measured what changed.

What changedDesignPeopleSource

up: Improves physical function

down: Decreases plasmatic ccf-mtDNA

down: Decreases IL-6

Trial12-week50 peoplemean 81.4 ± 5.6 years (frail)Older adults; both robust and frail groupsAging cell, Mar 4, 2025

What did studies of vivifrail multicomponent exercise protocol find?

4

Studies of vivifrail multicomponent exercise protocol measured 4 outcomes, among them apoptosis, IL-6 and plasmatic ccf-mtDNA.

Apoptosis

downin humans1

1 study
  1. Vivifrail multicomponent exercise protocol decreases apoptosis in humans (both groups).

    “as well as reduced cellular damage/apoptosis (reduced plasmatic ccf-nDNA, downregulated BAX, and upregulated BCL-2/BAX ratio)”

    Human trialboth groupsperipheral blood mononuclear cells12-week

    Effects of the VIVIFRAIL Exercise Protocol on Circulatory and Intracellular Peripheral Mediators Bridging Mitochondrial Dynamics and Inflammation in Robust and Frail Older People

    Aging cell

More on Apoptosis

IL-6

downin humans1

1 study
  1. Vivifrail multicomponent exercise protocol decreases IL-6 in humans (frail subjects only).

    “plasmatic IL6 and IL6/IL10 ratio were reduced in frail subjects uniquely”

    Human trialfrail subjects only12-week

    Effects of the VIVIFRAIL Exercise Protocol on Circulatory and Intracellular Peripheral Mediators Bridging Mitochondrial Dynamics and Inflammation in Robust and Frail Older People

    Aging cell

More on IL-6

Plasmatic ccf-mtDNA

downin humans1

1 study
  1. Vivifrail multicomponent exercise protocol decreases plasmatic ccf-mtDNA in humans (robust subjects).

    “Plasmatic ccf-mtDNA was significantly reduced in robust subjects”

    Human trialrobust subjects12-week

    Effects of the VIVIFRAIL Exercise Protocol on Circulatory and Intracellular Peripheral Mediators Bridging Mitochondrial Dynamics and Inflammation in Robust and Frail Older People

    Aging cell

More on Plasmatic ccf-mtDNA

Physical function

upin humans1

1 study
  1. Vivifrail multicomponent exercise protocol improves physical function in humans (both robust and frail groups).

    “Besides significant functional improvements across both groups”

    Human trialboth robust and frail groups12-week

    Effects of the VIVIFRAIL Exercise Protocol on Circulatory and Intracellular Peripheral Mediators Bridging Mitochondrial Dynamics and Inflammation in Robust and Frail Older People

    Aging cell

Latest